Takeda R&D chief awarded 125K RSUs

Plump Andrew Stewart reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Plump Andrew Stewart reported acquisition or exercise transactions in this Form 4 filing.

Takeda Pharmaceutical President of R&D Andrew Stewart Plump reported a new equity award in the form of restricted stock units (RSUs). He received 125,390 RSUs, each representing a contingent right to receive one American Depositary Share, as a compensation grant at no purchase price.

The RSUs vest in three equal annual installments beginning on July 1, 2027, meaning the award will be delivered over three years if vesting conditions are met. After this grant, he directly holds 931,962 American Depositary Shares and indirectly holds 281,307 American Depositary Shares through a trust.

Insider Trade Summary

Grant/Award: 125,390 shares

Grant/Award 2 txns

Insider Plump Andrew Stewart

Role President, R&D

Type	Security	Shares	Price	Value
Grant/Award	American Depositary Shares	125,390	$0.00	$0.00
holding	American Depositary Shares	--	--	--

Holdings After Transaction: American Depositary Shares — 931,962 shares (Direct); American Depositary Shares — 281,307 shares (Indirect, By Trust)

Footnotes (1)

1. F1. Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027.

Key Figures

RSU award size: 125,390 RSUs RSU vesting start: July 1, 2027 Direct ADS holdings: 931,962 American Depositary Shares +2 more

5 metrics

RSU award size 125,390 RSUs Grant of restricted stock units representing ADSs

RSU vesting start July 1, 2027 First of three equal annual vesting dates

Direct ADS holdings 931,962 American Depositary Shares Shares directly held after reported grant

Indirect ADS holdings 281,307 American Depositary Shares Shares held indirectly by trust

Grant price per RSU $0.0000 per unit Compensation award, not open-market purchase

Key Terms

restricted stock units (RSUs), American Depositary Shares, indirect ownership, grant, award, or other acquisition, +1 more

5 terms

restricted stock units (RSUs) financial

"Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share."

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

American Depositary Shares financial

"Each RSU represents a contingent right to receive one American Depositary Share."

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

indirect ownership financial

"American Depositary Shares with ownership type listed as indirect and nature of ownership described as By Trust."

grant, award, or other acquisition financial

"Transaction code A is described as Grant, award, or other acquisition for the RSU transaction."

President, R&D financial

"Andrew Stewart Plump is identified as an officer with the title President, R&D."

FAQ

What insider transaction did Takeda (TAK) disclose for Andrew Stewart Plump?

Takeda disclosed that President of R&D Andrew Stewart Plump received an award of 125,390 restricted stock units. Each RSU represents a contingent right to receive one American Depositary Share as part of his equity compensation package, rather than an open-market share purchase.

How many Takeda (TAK) American Depositary Shares does Andrew Stewart Plump hold after this filing?

Following the reported grant, Andrew Stewart Plump directly holds 931,962 American Depositary Shares of Takeda. In addition, he indirectly holds 281,307 American Depositary Shares through a trust, providing a picture of both his direct and indirect equity exposure to the company.

What are the vesting terms of Andrew Stewart Plump’s RSU award at Takeda (TAK)?

The 125,390 restricted stock units awarded to Andrew Stewart Plump vest in three equal annual installments. Vesting begins on July 1, 2027, meaning the RSUs will convert into American Depositary Shares over a three-year period, subject to applicable vesting conditions.

Is Andrew Stewart Plump’s Takeda (TAK) RSU grant an open-market purchase?

No, the grant is not an open-market purchase. The filing describes a compensation-related award of 125,390 restricted stock units at a price of $0.0000 per unit, reflecting an equity incentive grant rather than a transaction executed in the public market.

How is indirect ownership reported for Andrew Stewart Plump in this Takeda (TAK) Form 4?

The Form 4 shows 281,307 American Depositary Shares held indirectly for Andrew Stewart Plump by a trust. This line is classified as indirect ownership, indicating the shares are held through a separate entity rather than directly in his own name.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/06/2026 - 06:01 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Plump Andrew Stewart

(Last) (First) (Middle)

300 MASSACHUSETTS AVE.

(Street)

CAMBRIDGE MASSACHUSETTS 02139

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TAKEDA PHARMACEUTICAL CO LTD [ TAK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, R&D

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
American Depositary Shares	07/01/2026		A(1)		125,390	A	$0	931,962	D
American Depositary Shares								281,307	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027.

Remarks:

	/s/ Samuel Ntonme, by power of attorney, for Andrew S Plump	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)